CD36 as a Multiple-Ligand Signaling Receptor in Atherothrombosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-6182|9|1|42-55

ISSN： 1871-5257

Source： Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol.9, Iss.1, 2011-01, pp. : 42-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TP Receptor Antagonism: A New Concept in Atherothrombosis and Stroke Prevention

By  

Cerebrovascular Diseases, Vol. 27, Iss. 3, 2009-05 ,pp. : 20-27

Karger

Access to resources Recommend Favorite

Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator–activator receptor γ gene expression in macrophages

By Graessler J.   Pietzsch J.   Westendorf T.   Julius U.   Bornstein S.   Kopprasch S.  

Diabetologia, Vol. 50, Iss. 5, 2007-05 ,pp. : 1080-1088

Springer Publishing Company

Access to resources Recommend Favorite

Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques

By Aggarwal A.   Schneider D.J.   Terrien E.F.   Sobel B.E.   Dauerman H.L.  

The American Journal of Cardiology, Vol. 93, Iss. 1, 2004-01 ,pp. : 6-9

Elsevier

Access to resources Recommend Favorite

Pathophysiology of Human Genetic CD36 Deficiency

By Hirano K.-i.   Kuwasako T.   Nakagawa-Toyama Y.   Janabi M.   Yamashita S.   Matsuzawa Y.  

Trends in Cardiovascular Medicine, Vol. 13, Iss. 4, 2003-05 ,pp. : 136-141

Elsevier

Access to resources Recommend Favorite

Is CD36 Deficiency an Etiology of Hereditary Hypertrophic Cardiomyopathy?

By Tanaka T.   Sohmiya K.   Kawamura K.  

Journal of Molecular and Cellular Cardiology, Vol. 29, Iss. 1, 1997-01 ,pp. : 121-127

Academic Press

Access to resources Recommend Favorite